BOSTONGENE Trademark

Trademark Overview


On Monday, August 3, 2020, a trademark application was filed for BOSTONGENE with the United States Patent and Trademark Office. The USPTO has given the BOSTONGENE trademark a serial number of 90089889. The federal status of this trademark filing is REGISTERED as of Tuesday, August 17, 2021. This trademark is owned by BostonGene Corporation. The BOSTONGENE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing ...

Genetic testing for medical purposes, specifically, genomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, nam...
bostongene

General Information


Serial Number90089889
Word MarkBOSTONGENE
Filing DateMonday, August 3, 2020
Status700 - REGISTERED
Status DateTuesday, August 17, 2021
Registration Number6457963
Registration DateTuesday, August 17, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, non-downloadable software for use in clinical trial data management and for management of electronic health records
Goods and ServicesGenetic testing for medical purposes, specifically, genomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes
Pseudo MarkBOSTON GENE

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 10, 2021
Primary Code042
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2020
Primary Code044
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

Trademark Owner History


Party NameBostonGene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameBostonGene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Tuesday, August 17, 2021REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, July 13, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 12, 2021ASSIGNED TO LIE
Friday, July 9, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, June 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 25, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, June 24, 2021USE AMENDMENT ACCEPTED
Wednesday, June 9, 2021AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, June 9, 2021USE AMENDMENT FILED
Tuesday, June 8, 2021TEAS AMENDMENT OF USE RECEIVED
Friday, March 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 12, 2021NON-FINAL ACTION E-MAILED
Friday, March 12, 2021NON-FINAL ACTION WRITTEN
Wednesday, March 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION WRITTEN
Monday, November 23, 2020ASSIGNED TO EXAMINER
Tuesday, September 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM